Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Achieve Life Sciences Inc...

    NASDAQ: ACHV · Real-Time Price · USD
    2.23
    -1.28 (-36.47%)
    At close: Jun 27, 2025, 3:59 PM
    2.22
    -0.45%
    After-hours: Jun 27, 2025, 05:58 PM EDT

    Achieve Life Sciences Statistics

    Share Statistics

    Achieve Life Sciences has 34.69M shares outstanding. The number of shares has increased by 1% in one year.

    Shares Outstanding

    n/a
    		 34.69M

    Shares Change (YoY)

    n/a
    		 1%

    Shares Change (QoQ)

    n/a
    		 0.86%

    Owned by Institutions (%)

    n/a
    		 50.95%

    Shares Floating

    n/a
    		 29.37M

    Failed to Deliver (FTD) Shares

    n/a
    		 6,999

    FTD / Avg. Volume

    n/a
    		 2.72%

    Short Selling Information

    The latest short interest is 2.62M, so 7.56% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.62M

    Short % of Shares Out

    n/a
    		 7.56%

    Short % of Float

    n/a
    		 9.69%

    Short Ratio (days to cover)

    n/a
    		 8.32

    Valuation Ratios

    The PE ratio is -2.83 and the forward PE ratio is -4.76. Achieve Life Sciences's PEG ratio is 0.16.

    PE Ratio

    n/a
    		 -2.83

    Forward PE

    n/a
    		 -4.76

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 5.4

    P/FCF Ratio

    n/a
    		 -3.79

    PEG Ratio

    n/a
    		 0.16
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Achieve Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.48.

    Current Ratio

    n/a
    		 5.46

    Quick Ratio

    n/a
    		 5.46

    Debt / Equity

    n/a
    		 0.48

    Debt / EBITDA

    n/a
    		 -0.27

    Debt / FCF

    n/a
    		 -0.33

    Interest Coverage

    n/a
    		 -17.92

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,593,080

    Employee Count

    n/a
    		 25

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -24.78% in the last 52 weeks. The beta is 1.64, so Achieve Life Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.64

    52-Week Price Change

    n/a
    		 -24.78%

    50-Day Moving Average

    n/a
    		 2.99

    200-Day Moving Average

    n/a
    		 3.6

    Relative Strength Index (RSI)

    n/a
    		 53.11

    Average Volume (20 Days)

    n/a
    		 257,041

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -39.07M

    Net Income

    n/a
    		 -39.83M

    EBITDA

    n/a
    		 -37.42M

    EBIT

    n/a
    		 -37.65M

    Earnings Per Share (EPS)

    n/a
    		 -1.24
    Full Income Statement

    Balance Sheet

    The company has 12.75M in cash and 9.96M in debt, giving a net cash position of 2.79M.

    Cash & Cash Equivalents

    n/a
    		 12.75M

    Total Debt

    n/a
    		 9.96M

    Net Cash

    n/a
    		 2.79M

    Retained Earnings

    n/a
    		 -205.58M

    Total Assets

    n/a
    		 27.36M

    Working Capital

    n/a
    		 17.87M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.77M and capital expenditures 0, giving a free cash flow of -29.77M.

    Operating Cash Flow

    n/a
    		 -29.77M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -29.77M

    FCF Per Share

    n/a
    		 -0.93
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ACHV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ACHV is $12, which is 243.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 243.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 31, 2020. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Jul 31, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -10.41

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist